Want to join the conversation?
$ACN reported 4Q15 results with net revenues of $7.9Bil, up 1% in USD and 12% in local currency vs. 4Q14 and exceeded the guidance of $7.45-7.70Bil given in 3Q15. Pierre Nanterme, CEO said, "I am particularly pleased with our double-digit revenue growth in local currency for both the quarter and the year, which was broad-based across our business."
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.